Firms that produce, analyse, or use biological systems
on a micro
-
, cellular
-
, or molecular level or firms that develops
tools and supplies for these purposes.
Biotechnology
Food
Agriculture
Pharmaceuticals
Medical Technology
Forestry
Pulp & Paper
Environment
Instruments
& equipment
Chemistry
THE BIOTECH INDUSTRY:
•
Agrobiotechnology
-
plant improvement and biological
plant protection
•
Bioproduction
-
biomolecular or micro
-
organism production
•
Biotech tools and supplies
-
services, processes,
equipment and instruments for biotechnological use
•
Environmental biotechnology
-
soil, water, and waste
treatment
•
Functional food and feed
-
mainly probiotics
•
Pharmaceuticals and medicine
-
drug discovery and drug
development, diagnostics and medical technology
The Swedish biotech industry
Number of biotechnology companies
in different countries year 2000
0
200
400
600
800
1000
1200
1400
No. of
Companies
USA
Japan
Korea
Canada
Germany
UK
China
France
Sweden
Spain
Italy
Australia
Israel
Taiwan
Netherlands
Finland
Switzerland
Denmark
Belgium
Norway
Russia
South Africa
India
Estonia
Latvia
Lithuania
Poland
Slovakia
Country
0
200
400
600
800
1000
1200
1400
No. of
Companies
USA
Japan
Korea
Canada
Germany
UK
China
France
Sweden
Spain
Italy
Australia
Israel
Taiwan
Netherlands
Finland
Switzerland
Denmark
Belgium
Norway
Russia
South Africa
India
Estonia
Latvia
Lithuania
Poland
Slovakia
Country
Source: The Swedish Trade council,
”Global perspectives on bioscience 2002”
*
Number of companies and employees
Year
2677
3233
3391
3760
3975
0
20
40
60
80
100
120
140
160
180
200
1997
1998
1999
2000
2001
0
500
1000
1500
2000
2500
3000
3500
4000
4500
Number of
companies
Number of
employees
The regional distribution of the Swedish biotech industry 1999*
* The sizes of the circles are proportional to the number of employees/companies.
Only micro
-
, and small sized companies (<200 employees) are included.
The distribution is based on the seat of the county government.
No. of employees
No. of companies
Number of companies
0
20
40
60
80
100
120
1997
1998
1999
2000
2001
Agrobiotechnology
Bioproduction
Biotech tools & supplies
Environmental biotechnology
Functional food & feed
Pharmaceuticals & medicine
Number of
companies
Year
Number of employees
0
500
1000
1500
2000
2500
1997
1998
1999
2000
2001
Agrobiotechnology
Bioproduction
Biotech tools & supplies
Environmental biotechnology
Functional food & feed
Pharmaceuticals & medicine
Number of
employees
Year
Turnover
0
500
1000
1500
2000
2500
1997
1998
1999
2000
Year
Turnover
(MSEK)
Agrobiotechnology
Bioproduction
Biotech tools & supplies
Environmental biotechnology
Functional food & feed
Pharmaceuticals & medicine
Number of companies
pharmaceuticals & medicine
0
10
20
30
40
50
60
1997
1998
1999
2000
2001
Diagnostics
Drug delivery
Drug discovery & development
Medical technology
Number of
companies
Year
Number of employees in
pharmaceuticals & medicine
0
200
400
600
800
1000
1200
1997
1998
1999
2000
2001
Diagnostics
Drug delivery
Drug discovery & development
Medical technology
Number of
employees
Year
Median equity/assets ratio
Year
20
30
40
50
60
70
80
1997
1998
1999
2000
Finacial strength,
median (%)
Agrobiotechnology
Bioproduction
Biotech tools & supplies
Environmental biotechnology
Functional food & feed
Pharmaceuticals & medicine
Net profits/losses in surviving companies in
the different biotech sectors, 1998
–
2001
-
1200
-
1000
-
800
-
600
-
400
-
200
0
200
1998
1999
2000
2001
Year
MSEK
Total
Agrobiotechnology
Bioproduction
Biotech tools & supplies
Environmental biotechnology
Functional food & feed
Pharmaceuticals & medicine
Share of surviving companies with net profit
1998
-
2001 in total and in each sector
0
20
40
60
80
100
1998
1999
2000
2001
Year
Per cent
Agrobiotechnology
Bioproduction
Biotech tools & supplies
Environmental biotechnology
Functional food & feed
Pharmaceuticals & medicine
Total
Size of sector in Sweden
•
PHARMACEUTICALS AND MEDICAL TECHNOLOGY
Approximately 30 000 employees and a turnover of 60 billion SEK
•
BIOTECHNOLOGY
•
The
fourth largest biotechnology industry in Europe after
Great Britain, Germany, and France * and the ninth in the world
**
•
183 SMEs (< 500 emp. each), increase by 35% 1997
-
2001
•
About
4000 employees,
increase by 48% 1997
-
2001
•
Turnover 4.4 billion SEK (2000), increase by
30 % 1997
-
2000***
•
Increased financial strength
and
net losses 1997
-
2001
* European Commission; Ernst & Young
** The Swedish Trade Council
*** Fixed prices
Reasons for the development
UNTIL 1999
•
The science base
•
The presence of Astra and Pharmacia
•
An internationally growing market
•
Success stories inspires
•
Changed attitudes
•
Good availability of seed and venture capital
CHANGE DURING 2000
-
2002…2003
•
Development at the stock exchange
•
Cautious venture capital companies
•
Lack of seed capital
The Swedish science base in international comparison
THE SWEDISH SCIENTIFIC PERFORMANCE IN GENERAL
•
The trend is increased quantity but at the same time there are
signs of decreasing quality.
PERFORMANCE IN A SELECTION OF LIFE SCIENCE FIELDS
•
First, second or third ranking of publication volumes in relation to
population in the selected seven subject fields.
•
Five out of seven fields showed increasing shares of the world’s
total publication volume.
•
Four out of seven fields showed increased citation levels but
still Swedish citation levels are loosing their top position
1986
-
1989
1990
-
1993
1994
-
1997
1998
-
2001
Total
87
-
01
Biochemistry & Biophysics
2
2
2
2
2
Biotechnol & Appl Microbiol
3
4
3
1
2
Cell & Developmental Biol
3
3
2
2
2
Immunology
1
2
2
2
2
Microbiology
2
2
4
3
3
Molecular Biology & Genetics
2
2
3
2
2
Neurosciences & Behavior
1
1
1
1
1
Swedish ranking in relation to population
1986
-
2001
Relative citation levels in
biochemistry and biophysics
0.6
1.0
CANADA
DENMARK
EUROPEAN UNION
FINLAND
FRANCE
GERMANY
ISRAEL
NETHERLANDS
SWEDEN
SWITZERLAND
UK
USA
1.2
1.4
1.6
0.8
Relative citation levels in
neurosciences and behavior
0.4
0.6
0.8
1.0
1.2
1.4
CANADA
DENMARK
EUROPEAN UNION
FINLAND
FRANCE
GERMANY
ISRAEL
NETHERLANDS
SWEDEN
SWITZERLAND
UK
USA
0
5
10
15
20
25
30
35
40
1987-
1989
1990-
1992
1993-
1995
1996-
1998
1999-
2001
Year
Per cent
KAROLINSKA
INST
LUND UNIV
UPPSALA UNIV
GOTHENBURG
UNIV
UMEA UNIV
STOCKHOLM
UNIV
SLU
LINKOPING
UNIV
SMI
Volume shares for the nine most productive Swedish public
research organisations of the total Swedish publication volume
in biotechnology
-
related science, 1987
-
2001
Co
-
authorship pattern between organisations with the largest
publication volumes in biotechnology related science 1997
-
2001
’
0
1
2
3
4
1987
-
1989
1990
-
1992
1993
-
1995
1996
-
1998
1999
-
2001
The Swedish percentage of the world
´
s total
publication volume within a selection of life
science fields during
five periods (1987
-
2001)
0
1
2
87
-
91
88
-
92
89
-
93
90
-
94
91
-
95
92
-
96
93
-
97
94
-
98
95
-
99
96
-
00
97
-
01
Relative citation levels for Swedish articles within a selection
of life science fields during 1987
-
1997 (Index world=1)
Inventor origin for biotechnology patents
in the US patent system 1987
-
2001*
USA
63,9%
Great Britain
3,6%
Canada
2,6%
Germany
4,6%
Japan
11,4%
France
2,9%
Other
11,0%
* Sweden < 1%
0
1
2
3
1987
-
1989
1990
-
1992
1993
-
1995
1996
-
1998
1999
-
2001
Swedish inventor shares of the world’s total patenting volume
during five periods in different areas compared to the
Swedish average share in all fields 1987
-
2001
Number of patents for Astra and Pharmacia
0
10
20
30
40
50
60
70
80
YEAR
NUMBER OF PATENTS
AstraZeneca AB
Pharmacia Corporation
Enter the password to open this PDF file:
File name:
-
File size:
-
Title:
-
Author:
-
Subject:
-
Keywords:
-
Creation Date:
-
Modification Date:
-
Creator:
-
PDF Producer:
-
PDF Version:
-
Page Count:
-
Preparing document for printing…
0%
Σχόλια 0
Συνδεθείτε για να κοινοποιήσετε σχόλιο